C07K 14/135
Respiratory syncytial virus
C07K14/135 (Respiratory syncytial virus) appears on 21 US grants and 49 published applications in this corpus.
Search patents in C07K- Granted patents
- 21
- Published applications
- 49
- Assignees
- 36
- Inventors
- 98
- Latest grant
- 25 Feb 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 2 |
| 2014 | 2 | 0 |
| 2015 | 0 | 4 |
| 2016 | 0 | 2 |
| 2017 | 0 | 2 |
| 2018 | 0 | 2 |
| 2019 | 1 | 6 |
| 2020 | 1 | 2 |
| 2021 | 6 | 6 |
| 2022 | 2 | 3 |
| 2023 | 4 | 4 |
| 2024 | 1 | 7 |
| 2025 | 4 | 3 |
| 2026 | 0 | 5 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Recombinant metapneumovirus f proteins and their use25 Feb 2025US 12,233,124 B2Institute for Research in Biomedicine
- Stabilized soluble pre-fusion RSV F proteins25 Feb 2025US 12,234,264 B2Janssen Vaccines & Prevention B. V.
- Stabilized RSV F proteins and uses thereof25 Feb 2025US 12,234,265 B2Merck Sharp & Dohme Corp.
- Pepmixes to generate multiviral CTLs with broad specificity18 Feb 2025US 12,227,764 B2Baylor College of Medicine
- Pepmixes to generate multiviral CTLS with broad specificity14 May 2024US 11,981,923 B2Baylor College of Medicine
- Engineered paramyxovirus soluble fusion (f) proteins and related vaccines30 Jul 2026US 2026/0217772 A1The Scripps Research Institute
- Recombinant rsv vaccine: methods of making and using the same9 Jul 2026US 2026/0193671 A1Blue Lake Biotechnology, Inc.
- RSV Vaccines with Truncated G-Protein Mucin Domains30 Apr 2026US 2026/0115274 A1Butler University
- Pepmixes to generate multiviral ctls with broad specificity2 Apr 2026US 2026/0092256 A1Baylor College of Medicine
- Respiratory syncytial virus surface glycoprotein peptides, conjugates, and uses thereof12 Feb 2026US 2026/0041753 A1Dana-Farber Cancer Institute, Inc.
Most cited
By later US patents
- Stabilized soluble pre-fusion RSV F polypeptides7US 10,899,800 B2Janssen Vaccines & Prevention B. V. · 2021
- Stabilized pre-fusion RSV F proteins5US 10,953,087 B2Janssen Vaccines & Prevention B. V. · 2021
- Pepmixes to generate multiviral CTLs with broad specificity5US 11,118,164 B2Baylor College of Medicine · 2021
- Stabilized soluble pre-fusion RSV F proteins5US 11,155,583 B2Janssen Vaccines & Prevention B. V. · 2021
- Recombinant metapneumovirus F proteins and their use3US 10,420,834 B2Institute for Research in Biomedicine · 2019